Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 2 institutions in 2 countries.
Xin XueDepartment of Medicinal Chemistry, Nanjing University of Chinese Medicine, Nanjing 210023, China. 300203@njucm.edu.cn.
Gang BaoDepartment of Medicinal Chemistry, Nanjing University of Chinese Medicine, Nanjing 210023, China. 20161291@njucm.edu.cn.
Hai-Qing ZhangDepartment of Medicinal Chemistry, Nanjing University of Chinese Medicine, Nanjing 210023, China. 20161413@njucm.edu.cn.
Ning-Yi ZhaoDepartment of Pharmacy, Red Stone Health Industry International Limited, NO.10 Xianlin Street, Nanjing 210038, China. 047415246@njucm.edu.cn.
Yuan SunDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 43210, USA. gregwan@njucm.edu.cn.
Yue ZhangDepartment of Medicinal Chemistry, Nanjing University of Chinese Medicine, Nanjing 210023, China. smilezny@126.com.
Xiao-Long WangDepartment of Medicinal Chemistry, Nanjing University of Chinese Medicine, Nanjing 210023, China. sun.596@buckeyemail.osu.edu.
Nanjing University of Chinese Medicine · CNThe Ohio State University · US
Funding
National Natural Science Foundation of China 81502986Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) 15KJB350003
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
Drug DiscoveryQuantitative Structure-Activity RelationshipCell Line, TumorDrug Screening Assays, AntitumorHumansLigandsMolecular Docking SimulationMolecular Dynamics SimulationMolecular StructureProtein BindingProto-Oncogene Proteins c-mdm2Reproducibility of ResultsSmall Molecule LibrariesStructure-Activity RelationshipTumor Suppressor Protein p53LigandsMDM2 protein, humanProto-Oncogene Proteins c-mdm2Small Molecule LibrariesTumor Suppressor Protein p53fit qualityligand efficiencyMDM2/p53 protein-protein interactionvirtual screening
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
An Application of Fit Quality to Screen MDM2/p53 Protein-Protein Interaction Inhibitors. · full record | OpenQuestion